MATILDA AGYEMANG: Open Payments
NPI 1548637895 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 6 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $541 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $229 |
| Alkermes, Inc. | 1 | $123 |
Products named: INGREZZA, CAPLYTA, LYBALVI.
Industry payments across NC — which companies pay providers there.
